SSII — SS Innovations International, Inc. stock price, charts and financials

QT37SS Innovations International, Inc.

SS Innovations International, Inc. (NASDAQ: SSII) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
3.95
-0.03-0.75%
SSIIQT37SS Innovations International, Inc.·NASDAQ
3.95-0.75%
TA
Loading chart...
Screen all →
Snapshot
Index-P/E-EPS (ttm)-0.11Insider Own-Shs Outstand200.13MPerf Week14.37%
Market Cap796.52MForward P/E-EPS next Y-0.06Insider Trans0.50%Shs Float7.73MPerf Month1.02%
Enterprise Value794.36MPEG-EPS next Q-Inst Own-Short Float0.07%Perf Quarter-1.00%
Income-10.28MP/S16.44EPS this Y45.45%Inst Trans-Short Ratio2.27Perf Half Y-5.01%
Sales48.45MP/B14.31EPS next Y0.00%ROA-11.08%Short Interest131.07KPerf YTD-29.93%
Book/sh-P/C-EPS next 5Y-ROE-23.00%52W High9.92 -60.20%Perf Year-43.55%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-8.04%52W Low3.09 27.97%Perf 3Y156.77%
Dividend Est.-EV/EBITDA-Sales past 3/5Y247.60% -Gross Margin48.39%Volatility9.98% 8.82%Perf 5Y186.33%
Dividend TTM-EV/Sales16.40EPS Y/Y TTM-10.00%Oper. Margin-12.65%ATR (14)0.34Perf 10Y-
Dividend Ex-Date-Quick Ratio1.89Sales Y/Y TTM-9.52%Profit Margin-20.70%RSI (14)57.84Recom-
Dividend Gr. 3/5Y-Current Ratio2.54EPS Q/Q-SMA207.23%Beta-Target Price7.00
Payout0.00%Debt/Eq0.25Sales Q/Q120.00%SMA507.50%Rel Volume0.49Prev Close3.98
Employees483LT Debt/Eq0.05EarningsAug 10SMA200-20.88%Avg Volume67.34KPrice3.95
IPO DateOct 17, 2018Option/ShortYes / YesEPS/Sales Surpr.0.00% 0.00%Net Debt/EBITDA0.58Volume33,092Change-0.75%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-03-26ReiteratedLoop Capital Markets$7.00
Latest News
Jul-17-26
Jul-14-26
Jul-09-26
Jul-07-26
Jun-30-26
Jun-19-26
Jun-18-26
Jun-15-26
Company

SS Innovations International, Inc., situated in Fort Lauderdale, Florida, focuses on the development of sophisticated robotic systems for surgical use. Their offerings encompass the SSI Mantra, a specialized surgical robot, and SSI Mudra, a suite of surgical instruments designed to facilitate various operations, including robotic cardiac surgery. The company also provides SSI Maya, a dedicated platform for robotic surgical interventions, along with OMNI 3D HD, which delivers a real-time, high-definition 3D perspective of the surgical field within the operating room.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue194221610000
Cost of Goods Sold Incl. D&A132312510000
Gross Profit7208100000
Selling, General and Administrative Excl. Other2423252161131
Research and Development242100000
Other Operating Expense210-100000
Operating Income-20-8-19-21-6-1-1-3-1
Interest Expense011100000
Unusual Expense
Non-Operating Income (Expense)111000000
Net Income Before Taxes-19-8-19-21-6-1-1-3-1
Income Taxes040000000
Consolidated Net Income-19-12-19-21-6-1-1-3-1
Net Income From Continuing Operations-19-12-19-21-6-1-1-3-1
Net Income-19-12-19-21-6-1-1-3-1
EPS (Recurring)-0.13-0.06-0.11-0.16-1.41-0.52-0.48-1.57-0.46
EPS (Basic, Before Extraordinaries)-0.13-0.06-0.11-0.16-1.41-0.52-0.48-1.57-0.46
EPS (Diluted)-0.11-0.06-0.10-0.16-1.41-0.52-0.48-1.57-0.46
EBITDA-17-6-18-20-5-1-1-3-1
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio
Price To Sales Ratio37.2125.7064.2515.474.04
Gross Margin36.8447.6238.1016.670.00
Operating Margin-105.26-19.05-90.48-350.00-600.00
Net Margin-100.00-28.57-90.48-350.00-600.00
Shares Outstanding17919017112843222
Market Capitalization7071,0791,3499340126
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$10.99$8.80$6.61$4.42$2.23 Close Price0.00M1.30M2.60M3.90M5.20MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
MOLL FREDERIC Hdirector, 10 percent owner:Mar 06 '26Buy3.99501,2531,999,99910,775,485Mar 10
Adams Timothy P.DirectorMar 06 '26Buy3.99300,0001,197,0005,331,902Mar 10
Sudhir SrivastavaChairman and CEOMar 06 '26Buy4.01498,7532,000,000109,851,767Mar 10
Cohen Barry FCOO - AmericasApr 22 '25Buy8.976525,8488,866,888Jun 30
Cohen Barry FCOO - AmericasApr 17 '25Buy8.752001,7508,866,562Jun 30
Cohen Barry FCOO - AmericasApr 16 '25Buy9.501071,0178,843,780Apr 16
Cohen Barry FCOO - AmericasApr 14 '25Buy8.931039208,843,673Apr 16
Cohen Barry FCOO - AmericasApr 10 '25Buy8.932001,7868,843,570Apr 10
Cohen Barry FCOO - AmericasApr 09 '25Buy8.473002,5408,843,370Apr 10
Cohen Barry FCOO - AmericasApr 08 '25Buy9.165004,5808,843,070Apr 10
Cohen Barry FCOO - AmericasApr 02 '25Buy9.204203,8648,842,570Apr 02
Cohen Barry FCOO - AmericasApr 01 '25Buy9.722,57024,9838,842,150Apr 02
Cohen Barry FCOO - AmericasMar 31 '25Buy10.001001,0008,839,580Apr 02
MOLL FREDERIC Hdirector, 10 percent owner:Feb 20 '25Buy1.373,645,2245,001,24710,060,813Feb 24
SRIVASTAVA SUDHIRChairman and CEOFeb 20 '25Sale1.373,645,2245,001,24791,338,146Feb 21
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.